Takeda Pharmaceutical
311 hedge funds and large institutions have $1.98B invested in Takeda Pharmaceutical in 2020 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 82 increasing their positions, 98 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
10% less call options, than puts
Call options by funds: $54.6M | Put options by funds: $60.5M
16% less repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 98
43% less funds holding in top 10
Funds holding in top 10: 7 → 4 (-3)
Holders
311
Holding in Top 10
4
Calls
$54.6M
Puts
$60.5M
Top Buyers
| 1 | +$136M | |
| 2 | +$22.3M | |
| 3 | +$15.2M | |
| 4 |
TAM
TFG Asset Management
Grand Cayman,
Cayman Islands
|
+$14.4M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$11.9M |
Top Sellers
| 1 | -$43.4M | |
| 2 | -$27.8M | |
| 3 | -$23.1M | |
| 4 |
Citigroup
New York
|
-$17.6M |
| 5 |
AC
Adelphi Capital
London,
United Kingdom
|
-$12.5M |